-
S651969-50mgSARS-CoV-2-IN-7 inhibits viral replication with a nanomolar IC 50 value (844 nM) in SARS-CoV-2-infected Vero E6 cells.Form:Solid
-
S651969-5mgSARS-CoV-2-IN-7 inhibits viral replication with a nanomolar IC 50 value (844 nM) in SARS-CoV-2-infected Vero E6 cells.Form:Solid
-
S656903-1mlSARS-CoV-2-IN-7 inhibits viral replication with a nanomolar IC 50 value (844 nM) in SARS-CoV-2-infected Vero E6 cells.
-
S650398-100mgSSAA09E2 is an inhibitor of SARS-CoV (Severe acute respiratory syndrome-Coronavirus) replication, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV , Angiotensin Converting Enzyme-2 (ACE2)Form:SolidIC50&
-
S650398-10mgSSAA09E2 is an inhibitor of SARS-CoV (Severe acute respiratory syndrome-Coronavirus) replication, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV , Angiotensin Converting Enzyme-2 (ACE2)Form:SolidIC50&
-
S650398-1mgSSAA09E2 is an inhibitor of SARS-CoV (Severe acute respiratory syndrome-Coronavirus) replication, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV , Angiotensin Converting Enzyme-2 (ACE2)Form:SolidIC50&
-
S650398-25mgSSAA09E2 is an inhibitor of SARS-CoV (Severe acute respiratory syndrome-Coronavirus) replication, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV , Angiotensin Converting Enzyme-2 (ACE2)Form:SolidIC50&
-
S650398-50mgSSAA09E2 is an inhibitor of SARS-CoV (Severe acute respiratory syndrome-Coronavirus) replication, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV , Angiotensin Converting Enzyme-2 (ACE2)Form:SolidIC50&
-
S650398-5mgSSAA09E2 is an inhibitor of SARS-CoV (Severe acute respiratory syndrome-Coronavirus) replication, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV , Angiotensin Converting Enzyme-2 (ACE2)Form:SolidIC50&
-
S656255-1mlSSAA09E2 is an inhibitor of SARS-CoV (Severe acute respiratory syndrome-Coronavirus) replication, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV , Angiotensin Converting Enzyme-2 (ACE2)IC50& Target:SARS-CoV
-
T406629-50TProduct DescriptionAs a biological macromolecule, mRNA can only be synthesized on a large scale by in vitro transcription (IVT). T7 promoter is currently one of the most efficient transcriptional promoters, so T7 RNA Polymerase (T7 RNA Polymerase)
-
T406475-5000UProduct DescriptionT7 promoters are currently the most efficient type of promoters. Therefore, T7 RNA polymerase can be used for in vitro transcription to obtain more synthetic products. T7 RNA polymerase is also the RNA polymerase with the best